香港聯合交易所有限公司與證券及期貨事務監察委員會對本申請版本的內容概不負責，對其準確 性或完整性亦不發表任何意見，並明確表示概不就因本申請版本全部或任何部分內容而產生或因 倚賴該等內容而引致的任何損失承擔任何責任。 Shenzhen Xiaokuo Technology Co., Ltd. 深 圳 小 闊 科 技 股 份 有 限 公 司 （「本公司」） （ 於中華人民共和國註冊成立的股份有限公司） 的申請版本 警告 本 申 請 版 本 乃 根 據 香 港 聯 合 交 易 所 有 限 公 司（「 聯 交 所」）與 證 券 及 期 貨 事 務 監 察 委 員 會 （「證監會」）的要求而刊發，僅用作提供資料予香港公眾人士。 本申請版本為草擬本，其內所載資料並不完整，亦可能會作出重大變動。 閣下閱覽本 文件，即代表 閣下知悉、接納並向本公司、本公司的獨家保薦人、整體協調人、顧問 或包銷團成員表示同意： 倘於適當時候向香港公眾人士提出要約或邀請，有意投資者務請僅依據與香港公司註冊 處處長註冊的本公司招股章程作出投資決定；招股章程的文本將於發售期內向公眾人士 提供。 (a) 本文件僅為向香港公眾人士提供有關本公司的資料， ...

Summary of the Conference Call for稳健医疗 Company Overview - **Company Name**: 稳健医疗 (Steady Medical) - **Founded**: 1991 - **Business Segments**: Medical supplies and consumer products - **2023 Total Revenue**: Approximately 8.2 billion RMB - **2023 Net Profit**: Approximately 580 million RMB - **Revenue Breakdown**: Medical supplies revenue approximately 3.9 billion RMB (47%), consumer products revenue approximately 4.3 billion RMB (52%) [2][4] Key Insights and Arguments - **Growth in Consumer Products**: The consumer products segment is experiencing rapid growth, with a significant increase in revenue share, reaching 52% in 2023. The company anticipates accelerated growth in 2024, driven by a robust online membership base exceeding 56 million and a steady expansion of offline stores to 444 [2][4][8]. - **Quality Control and Brand Strength**: The company has capitalized on quality control and cost-effectiveness to enhance brand strength, especially in personal care products like sanitary napkins. This has allowed it to capture market share from domestic brands facing quality issues [2][9][11]. - **Marketing Strategy**: In 2024, the company plans to intensify marketing efforts, promoting its all-cotton and medical-grade labels, which is expected to lead to a year-on-year revenue increase of over 50% in Q4 and early 2025 [2][15][18]. - **Product Safety Concerns**: There is a high consumer demand for safety in personal care products, particularly sanitary napkins, due to past quality issues with international brands. This has created a market opportunity for companies with stringent quality controls [9][10][12]. Financial Projections - **Future Revenue Growth Targets**: The company has set ambitious revenue growth targets of 13% and 18% for 2025 and 2026, respectively, reflecting confidence in new product categories [2][7]. - **Net Profit Forecast**: Expected net profits for 2024, 2025, and 2026 are 800 million RMB, 1.05 billion RMB, and 1.23 billion RMB, representing year-on-year growth rates of 43%, 26%, and 18% [5][27]. Market Dynamics - **Market Trends**: The high-end medical dressing market is projected to grow significantly, with the company aiming to expand its presence in the U.S. market through the acquisition of GRI, which will help mitigate tariff risks [5][24]. - **Consumer Product Market Size**: The cotton towel market is expected to grow from approximately 54 billion RMB in 2023 to 64.4 billion RMB by 2026, with the company targeting a market share of 2.9% [25][26]. Strategic Initiatives - **Acquisition of GRI**: The acquisition of GRI is aimed at expanding the company's U.S. customer base and avoiding tariffs on medical supplies, while also leveraging GRI's production capabilities in various countries [5][24]. - **Channel Strategy**: The company is focusing on both online and offline channels, with a significant increase in membership and store count, enhancing its market reach [19][23]. Risks and Concerns - **Investor Sentiment**: Some investors express concerns about the sustainability of the company's growth, viewing recent performance as potentially short-term. However, the company believes that the high consumer demand for personal care products will support long-term growth [30]. - **Valuation Considerations**: The company is currently valued at approximately 26 times earnings, with potential for a 15% increase in market value, supported by strong performance in personal care and medical segments [29]. Conclusion - **Investment Recommendation**: The company presents a compelling investment opportunity, particularly in the medical and personal care sectors, due to its strong market position, growth potential, and effective marketing strategies [31].